NDC 71336-1002

OXLUMO

Lumasiran

OXLUMO is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Alnylam Pharmaceuticals, Inc.. The primary component is Lumasiran.

Product ID71336-1002_21948bd3-1a10-4a17-a5cb-f6f19157af54
NDC71336-1002
Product TypeHuman Prescription Drug
Proprietary NameOXLUMO
Generic NameLumasiran
Dosage FormInjection, Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2020-11-23
Marketing CategoryNDA / NDA
Application NumberNDA214103
Labeler NameAlnylam Pharmaceuticals, Inc.
Substance NameLUMASIRAN
Active Ingredient Strength95 mg/.5mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 71336-1002-1

1 VIAL, SINGLE-USE in 1 CARTON (71336-1002-1) > .5 mL in 1 VIAL, SINGLE-USE
Marketing Start Date2020-11-23
NDC Exclude FlagN
Sample Package?N

Drug Details


Trademark Results [OXLUMO]

Mark Image

Registration | Serial
Company
Trademark
Application Date
OXLUMO
OXLUMO
88576813 not registered Live/Pending
Alnylam Pharmaceuticals, Inc.
2019-08-13
OXLUMO
OXLUMO
88352142 not registered Live/Pending
Alnylam Pharmaceuticals, Inc.
2019-03-22
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.